About TBD Pharmatech

Pharmaceutical API CDMO

Established in 2006, TBD Pharmatech (formerly TBD-Biodiscovery) is a Contract Development and Manufacturing Organization (CDMO) specializing in small-molecule Active Pharmaceutical Ingredients (APIs) and fine chemicals. Our comprehensive services encompass

  • Full-range small-molecule API development and tech transfer
  • Clinical and commercial batch manufacturing
  • Custom synthesis, analytical services, and regulatory support

Operating from two GMP-certified facilities in Tartu, Estonia—the Tiigi site and the newly constructed Välja site—we are committed to delivering tailored solutions to pharmaceutical and biotech companies worldwide. Our international team ensures compliance with global regulatory standards, fostering enduring partnerships built on quality and client satisfaction.

Get to Know Our team

Facilities

TBD Pharmatech operates two state-of-the-art facilities in Tartu, Estonia.

Tiigi Site: Our original GMP-certified facility, operational since 2008, equipped with advanced laboratories and production units for small-molecule API development and manufacturing.

Välja Site: Our newly constructed facility, initiated in 2024, designed to significantly expand our operational capacity. This site enhances our capabilities in pilot production and commercial manufacturing.

Certifications

ISO 9001

Quality is embedded into every aspect of our operations—from early-stage development to GMP-certified manufacturing. Our facilities, processes, and teams are structured around a deep-rooted culture of compliance and continuous improvement. At TBD Pharmatech, this standard makes a part of our culture. Every process, from feasibility study to commercial dispatch, is mapped, measured and improved.

Robust change-control and CAPA programs mean lessons travel fast while quality standards keep us audit-ready at all times.

The result is predictable lead times, right-first-time documentation, and a level of reliability that lets clients plan their work with confidence.

Good Manufacturing Practice (GMP)

Good Manufacturing Practices (GMP) are the guidelines and regulations that govern the manufacturing, testing, and quality assurance of pharmaceuticals, including active pharmaceutical ingredients (APIs), finished dosage forms, and medical devices.

Our facilities operate under current EU cGMP licences, integrating risk-based thinking into every stage of production: qualified suppliers and materials, segregated flows, validated equipment, and real-time environmental monitoring. Batch records are reviewed by independent Quality Assurance before a Qualified Person (QP) releases them, and periodic self-inspections and third-party audits drive continuous refinement. This discipline guarantees lot-to-lot consistency, full traceability, and compliance with authorities’ expectations—delivering the trust our partners and their patients rely on.

Good Distribution Practice (GDP)

Good Distribution Practice sets the standards for sourcing, handling, storage, and transport of pharmaceutical materials so their quality is preserved all the way from supplier to patient. Operating under an EU GDP licence, TBD Pharmatech applies the same discipline to logistics that we apply to manufacturing, from goods-in to final dispatch.

Every consignment is released by Qualified Persons (QPs) only after GDP records have been reviewed, while routine self-inspections and third-party audits keep our system in a state of continuous improvement. The result is an unbroken, compliant supply chain that protects product integrity and gives customers confidence that every batch will arrive exactly as specified.

Download presentation

Discover our capabilities in one deck. Download the TBD Pharmatech Overview Presentation below.


    TBD Pharmatech over the years

    From Foundation to the Forefront

    2025

    Completion of Välja Facility Construction & Operational Launch

    Read more

    2024

    New Välja Facility Construction

    Read more

    2023

    Manufacturing Expansion in Tartu

    Read more

    2022

    Team Growth & Rebrand

    Read more

    2020

    Awards & New Facilities Planning

    Read more

    2019

    Global Reach & Strategic Investment

    Read more

    2018

    Team Expansion & ISO 9001

    Read more

    2013

    Broad Partnerships & New Capabilities

    Read more

    2012

    Transition to CDMO

    Read more

    2010

    Niche Expertise & New Initiatives

    Read more

    2008

    EU GMP Certification

    Read more

    2007

    Laboratory Expansion & Regional Collaboration

    Read more

    2006

    Founding

    Read more